Can only work with info I get. Logical events being disturbed by illogical action is hard to predict. Market been saying deal for a while now, took time to get fully there.

The first technical pattern on $SPCX has emerged! BULLISH MONOCAMEL

You know what they say… you can't keep a data storage stock down. Time to watch for defense on the $SNDK trendline 🛡️

Here's the filter I use to Identity Sales and Earnings outliers - PEAD (Post Earnings Announcement Drift) - Growth score > 80 - Sales Rank > 80 Here are some names. NBIS, ARM, LASR, VIAV, STRL, HPE, SLP, STX, AUGO, AAP, CDE, KLIC, EQX, BWIN, MPAA, CBZ, BIDU, INSW, KMT, RSI, COCO, LLY, ORA, NVO, CENTA

Just as a wand chooses its wizard, your edge should match your temperament. Mine: relative strength, high-volume signatures, IPOs, unusual sales & earnings. Those edges discover the stocks that are relevant. #TheStrat tells me when and where to enter. Find what fits you. Then lean into it.

20% oscillator It’s the same thing time and time again. Buy stocks when the bullish reading is low and market is bullish, sell them when it’s high. Understand the micro cycle within the macro cycle you will not have trouble with timing ever again Credit to @PradeepBonde of course, but this concept is wonderful!

A very sharp question, KC. Turmeric (Curcuma longa) is native to India, but the answer is an absolute yes. The ancient spice trade routes were already highly active. The Ebers Papyrus (c. 1550 BCE) explicitly documents the use of imported turmeric for deep wound healing and tissue repair. They didn't have the modern word 'curcumin', but they mapped its exact physiological function: closing structural gaps and restoring the 'Ka' (cellular vitality). The blueprint was already global.

None is greater than another. The onion is not greater than the avocado. The avocado is not greater than the cilantro. The cilantro is not greater than the lime. They are all equally important when making great guacamole.

The Egyptians didn't guess; they treated Wekhedu (which we now call LPS-endotoxemia / leaky gut) with a strict 3-phase botanical protocol. Modern gastroenterology is only just catching up to it: 1. Clear the Source (Myrrh & Garlic to strip bacterial/parasitic overgrowth). 2. Seal the Metu Channels (Aloe & Slippery Elm mucilage to close intestinal permeability). 3. Restore the Ka (Turmeric & Ginger to reset the cellular voltage). We still use this exact 3,500-year-old blueprint today. The physiology never changed.

Before Athens. Before Rome. Before the first Greek physician was born. Egypt had a complete model of disease. Ka: the vital charge that sustains the living. Sekhem: the power streaming through matter. Wekhedu: toxic residue born in the gut — spreading through 46 body channels to poison every tissue system. 3000 BCE. The oldest peer review in medicine starts here.

Silica also pulls hard metals out of your body

Silica increased hair thickness by 12.8% in 9 months. The placebo group saw zero change. 10mg a day. Double-blind, placebo-controlled. Hair got measurably thicker and stronger. The placebo group — nothing. The second most abundant element on earth — and almost nobody gets enough of it. 85% of soils are now depleted. That means your food barely contains it anymore. And your hair, skin, and nails are paying for it. Silica drives collagen synthesis, strengthens keratin, increases skin elasticity, and supports nutrient delivery to hair follicles. Your hair isn’t thinning because of genetics. It’s thinning because of a mineral you’ve never thought about. My favorite sources: - Nettle tea — one of the richest plant sources - Orthosilicic acid (ch-OSA) — the form used in clinical trials - Fiji Water — 85-93mg of natural silica per liter

I supplement silica through concrete dust exposure

$SPCX space x pre ipo on hyperliquid and is already down -25% from its initial open. $205 to $160 Goes to show the sentiment going into the IPO in regards to its price.

MSCI's Long Base Awaiting the Push into Space There's an old saying among traders — one we covered in our 15 Stock Market Sayings. «The longer the base, the higher the space.» The idea behind it is almost physical. When a stock moves sideways for months — sometimes years — something happens beneath the surface. Smart money accumulates. Weak hands give up. Tension builds like a compressed spring. And the longer the compression lasts, the more powerful the release when the price finally breaks above resistance. Long bases signal not short-lived spikes but durable, reliable trends. Now look at MSCI over the past few years. This is the «Good Chart» we promised — and it's a beauty. Since the 2021 high — around $650 — the stock never decisively cleared it. A ceiling the price kept bumping into, year after year. A textbook multi-year consolidation beneath a clear lid. But look closer at the floor. Because the second signal is hiding there — and it's the one that matters most. Each pullback, the price stops falling a little earlier, a little higher than the last. 2022. 2023. 2024. 2025. 2026. Five valleys, each one shallower than the one before. Higher lows. It's the most bullish footprint a chart can leave. Every dip that refuses to go as deep as the last is a quiet message: the sellers are running out of ammunition, and the buyers are stepping in earlier, more confidently, at ever-higher prices. The floor isn't flat. It's tilting upward — pressing the price against that $650 ceiling like a rising tide against a dam. A compressed (coiling) spring, squeezed from below. And right now, as I write this, MSCI trades again at the upper edge of that years-long range, exactly where the old ceiling sat. The base is long. The lows are rising. The spring is wound to its maximum. The price stands at the threshold. Should MSCI break out decisively here (lots of buying interest in the form of volume), it wouldn't just be a technical signal. It would be the confirmation of the entire story: an indispensable business that profits from every rising market, that nobody can leave, that consists almost entirely of margin — and whose stock, after years of patience, is finally taking its run-up. A “Good Story” and a “Good Chart”, finally pointing the same direction. Bogle taught the world to buy the haystack. MSCI decides which straws go in it — and clips a fee on every bale. The base is laid. The lows are climbing. The space above is vast. MSCI is waiting in ambush.

MSCI's Long Base Awaiting the Push into Space There's an old saying among traders — one we covered in our 15 Stock Market Sayings. «The longer the base, the higher the space.» The idea behind it is almost physical. When a stock moves sideways for months — sometimes years — something happens beneath the surface. Smart money accumulates. Weak hands give up. Tension builds like a compressed spring. And the longer the compression lasts, the more powerful the release when the price finally breaks above resistance. Long bases signal not short-lived spikes but durable, reliable trends. Now look at MSCI over the past few years. This is the «Good Chart» we promised — and it's a beauty. Since the 2021 high — around $650 — the stock never decisively cleared it. A ceiling the price kept bumping into, year after year. A textbook multi-year consolidation beneath a clear lid. But look closer at the floor. Because the second signal is hiding there — and it's the one that matters most. Each pullback, the price stops falling a little earlier, a little higher than the last. 2022. 2023. 2024. 2025. 2026. Five valleys, each one shallower than the one before. Higher lows. It's the most bullish footprint a chart can leave. Every dip that refuses to go as deep as the last is a quiet message: the sellers are running out of ammunition, and the buyers are stepping in earlier, more confidently, at ever-higher prices. The floor isn't flat. It's tilting upward — pressing the price against that $650 ceiling like a rising tide against a dam. A compressed (coiling) spring, squeezed from below. And right now, as I write this, MSCI trades again at the upper edge of that years-long range, exactly where the old ceiling sat. The base is long. The lows are rising. The spring is wound to its maximum. The price stands at the threshold. Should MSCI break out decisively here (lots of buying interest in the form of volume), it wouldn't just be a technical signal. It would be the confirmation of the entire story: an indispensable business that profits from every rising market, that nobody can leave, that consists almost entirely of margin — and whose stock, after years of patience, is finally taking its run-up. A “Good Story” and a “Good Chart”, finally pointing the same direction. Bogle taught the world to buy the haystack. MSCI decides which straws go in it — and clips a fee on every bale. The base is laid. The lows are climbing. The space above is vast. MSCI is waiting in ambush.

you can add 'Volatility' Week above 5%, the result will be mostly intact

🚨 INDIA MAY HAVE JUST WITNESSED ONE OF ITS BIGGEST ACCOUNTING FRAUDS EVER. SEBI alleges that Rajesh Exports, one of India's most well known gold companies and a Fortune Global 500 firm, faked $158 billion in revenue, 99.8% of everything it ever claimed to earn over the last 5 years. Rajesh Exports owns a Swiss gold refiner called Valcambi SA through overseas subsidiaries. The parent company booked the full value of refined gold as its own revenue, even though it never owned the gold. It only held it temporarily for refining on behalf of customers. Valcambi's own audited financials show it generated less than 0.5% of what Rajesh Exports was claiming as group revenue. When SEBI asked for subsidiary financial records, Rajesh Exports repeatedly refused, citing Swiss privacy laws. SEBI is legally authorised under those same laws to request the records. SEBI also found $1.3 billion in recorded transactions with a firm called Affluence Shares and Stocks. Affluence told SEBI directly that Rajesh Exports was never its client, no agreement existed, and no trades were ever executed. SEBI alleged those entries were fabricated to match gold derivative trades the owner was running through his personal account using company funds transferred without board approval. Owner Rajesh Mehta has been banned from all securities market activity and a forensic audit has been ordered. LIC, India's largest state insurer, owns 10.8% of the company. The company has denied all charges and plans to contest the order.

Update from Monday's scans, and tough news. My cancer progressed. The chest and lungs are holding the line — but there's clear progression in my liver and abdomen. My care team has stopped my current treatment and I'm pivoting to a phase I clinical trial I've been working on as a backup for months. Here's what I'll say: I saw this fork coming and I prepared for it but this hurts. I am anxious and fearful. I will be walking into this standing up, still fighting, and surrounded by people who refuse to quit with me. I lost this round. The fight is not over. We do not give up. 🙏

For the opportunity. Perhaps buy